These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Long-term oral lysine supplementation in lysinuric protein intolerance. Tanner LM; Näntö-Salonen K; Niinikoski H; Huoponen K; Simell O Metabolism; 2007 Feb; 56(2):185-9. PubMed ID: 17224331 [TBL] [Abstract][Full Text] [Related]
4. Hyperdibasicaminoaciduria, hyperammonemia, and growth retardation: Treatment with arginine, lysine, and citrulline. Awrich AE; Stackhouse WJ; Cantrell JE; Patterson JH; Rudman D J Pediatr; 1975 Nov; 87(5):731-8. PubMed ID: 1185337 [TBL] [Abstract][Full Text] [Related]
5. Oral supplementation corrects plasma lysine concentrations in lysinuric protein intolerance. Lukkarinen M; Näntö-Salonen K; Pulkki K; Aalto M; Simell O Metabolism; 2003 Jul; 52(7):935-8. PubMed ID: 12870174 [TBL] [Abstract][Full Text] [Related]
6. [Protein intolerance with lysinuria. Value of orotic aciduria in adjusting treatment with citrulline]. de Parscau L; Vianey-Liaud C; Hermier M; Divry P; Guibaud P Arch Fr Pediatr; 1988 Dec; 45(10):809-12. PubMed ID: 3149174 [TBL] [Abstract][Full Text] [Related]
7. Lysinuric protein intolerance. Simell O; Perheentupa J; Rapola J; Visakorpi JK; Eskelin LE Am J Med; 1975 Aug; 59(2):229-40. PubMed ID: 1155480 [TBL] [Abstract][Full Text] [Related]
8. Effect of lysine infusion on urea cycle in lysinuric protein intolerance. Lukkarinen M; Näntö-Salonen K; Pulkki K; Mattila K; Simell O Metabolism; 2000 May; 49(5):621-5. PubMed ID: 10831173 [TBL] [Abstract][Full Text] [Related]
9. Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome: low creatine excretion and effect of citrulline, arginine, or ornithine supplement. Dionisi Vici C; Bachmann C; Gambarara M; Colombo JP; Sabetta G Pediatr Res; 1987 Sep; 22(3):364-7. PubMed ID: 3116497 [TBL] [Abstract][Full Text] [Related]
10. Oral administration of urea cycle intermediates in lysinuric protein intolerance: effect on plasma and urinary arginine and ornithine. Rajantie J; Simell O; Perheentupa J Metabolism; 1983 Jan; 32(1):49-51. PubMed ID: 6401349 [TBL] [Abstract][Full Text] [Related]
11. [Lysinuric protein intolerance]. Behbehani AW; Gahr M; Schröter W Monatsschr Kinderheilkd; 1983 Nov; 131(11):784-7. PubMed ID: 6420670 [TBL] [Abstract][Full Text] [Related]
13. Lysinuric protein intolerance. Basolateral transport defect in renal tubuli. Rajantie J; Simell O; Perheentupa J J Clin Invest; 1981 Apr; 67(4):1078-82. PubMed ID: 7204568 [TBL] [Abstract][Full Text] [Related]
14. Intestinal absorption in lysinuric protein intolerance: impaired for diamino acids, normal for citrulline. Rajantie J; Simell O; Perheentupa J Gut; 1980 Jun; 21(6):519-24. PubMed ID: 6776014 [TBL] [Abstract][Full Text] [Related]
15. "Basolateral" and mitochondrial membrane transport defect in the hepatocytes in lysinuric protein intolerance. Rajantie J; Simell O; Perheentupa J Acta Paediatr Scand; 1983 Jan; 72(1):65-70. PubMed ID: 6407277 [TBL] [Abstract][Full Text] [Related]
16. Lysinuric protein intolerance. Urinary amino acid excretion at 2 and 9 days of age. Candito M; Vianey-Saban C; Ferraci JP; Bébin B; Chazalette JP; Sebag F; Mathieu M; Chambon P J Inherit Metab Dis; 1994; 17(2):252-3. PubMed ID: 7967486 [No Abstract] [Full Text] [Related]
17. Oral administration of epsilon N-acetyllysine and homocitrulline in lysinuric protein intolerance. Rajantie J; Simell O; Perheentupa J J Pediatr; 1983 Mar; 102(3):388-90. PubMed ID: 6402575 [TBL] [Abstract][Full Text] [Related]
18. Oral administration of arginine and citrulline in the treatment of lysinuric protein intolerance. Mizutani N; Kato T; Maehara M; Watanabe K; Ban M Tohoku J Exp Med; 1984 Jan; 142(1):15-24. PubMed ID: 6719441 [TBL] [Abstract][Full Text] [Related]